Hervycta 440 + Injection

By Hervycta

Rx

1 Injection in a Vial

Composition icon

Composition

Trastuzumab(440mg)

Manufacturer - Dr Reddy's Laboratories Ltd icon

Manufacturer - Dr Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Expires on or after icon

Expires on or after

July, 2025

About Hervycta 440 + Injection

Hervycta 440 + Injection is a medication utilized in the treatment of breast and stomach cancer. Its mechanism of action involves targeting and destroying cancer cells by inhibiting the HER2 (human epidermal growth factor receptor protein). Administered via injection by a qualified healthcare professional, the dosage and frequency of Hervycta 440 + Injection are determined by your doctor based on your specific condition and may be adjusted as necessary. It is crucial to strictly adhere to your doctor's instructions to avoid potential serious side effects. While it may take some time for the full benefits of the medication to be evident, it is important not to discontinue treatment without consulting your doctor.

Common side effects of Hervycta 440 + Injection may include nausea, headache, rash, insomnia, and the potential for increased susceptibility to infections due to a decrease in blood cell count. Regular blood tests are essential to monitor blood cell levels, as well as heart, liver, and blood uric acid levels. It is vital to promptly notify your doctor if you experience symptoms such as breathlessness, cough, shivering, or swelling of the legs and arms while undergoing treatment with this medication.

Given the potential for interactions with other medications, it is important to inform your healthcare team about all medications you are currently taking. Hervycta 440 + Injection is not recommended during pregnancy or while breastfeeding. It is advised for both males and females to use effective contraception during treatment to prevent pregnancy.


Benefits

Hervycta 440 + Injection offers valuable benefits in treating both breast cancer and stomach cancer. In cases of breast cancer where other medications have not shown significant improvement, this injection plays a crucial role in halting cancer growth and preventing it from spreading further. It is particularly effective in relieving symptoms associated with breast cancer, such as breast lumps, bloody discharge from the nipple, and changes in the shape or texture of the breast. Administered by a doctor or nurse, following the instructions diligently can maximize the benefits of this treatment.


Similarly, in stomach cancer, also known as gastric cancer, Hervycta 440 + Injection proves to be a powerful tool in combating the disease. Stomach cancer can manifest in various forms, affecting different parts of the stomach with varying degrees of severity. This injection works by targeting and eliminating cancer cells while also impeding their growth and spread within the body. Adhering closely to the doctor's guidance is essential to ensure the maximum positive impact of this medication.


Overall, Hervycta 440 + Injection offers hope and relief to individuals battling breast cancer and stomach cancer. Its ability to halt cancer progression, alleviate symptoms, and inhibit further spread makes it a valuable treatment option for patients in need.


How to use the Hervycta 440 + Injection

To use Hervycta 440 + Injection, it is important to have a healthcare professional administer the medicine to you. Your doctor or nurse will be the one to give you the injection, so it is crucial not to try to administer it yourself. This medicine should only be handled by trained individuals to ensure it is properly and safely given to you. By following your healthcare provider's instructions and allowing them to administer the injection, you can help ensure that you are receiving the correct dosage and getting the most benefit from the medication. Remember, do not attempt to self-administer Hervycta 440 + Injection.


Uses of Hervycta 440 + Injection

The Hervycta 440 + Injection is utilized in aiding the treatment of breast cancer and stomach cancer. It is commonly prescribed by healthcare providers to assist patients in managing these specific types of cancer. This injection serves as an integral part of the overall therapy plan designed to combat breast cancer and stomach cancer effectively.


What conditions Hervycta 440 + Injection treats?

Hervycta 440 + Injection is used to treat breast and stomach cancer by inhibiting HER2 protein, stopping cancer growth and spread. For breast cancer, it relieves symptoms like lumps or nipple discharge. For stomach cancer, it targets cancer cells to prevent further growth. Regular blood tests are needed due to potential decrease in blood cells. Side effects include nausea, headache, rash, and infection. Consult your doctor if you experience breathlessness, cough, or swelling. Inform your healthcare provider of all medications used and avoid pregnancy during treatment. Follow your doctor's instructions carefully for optimal benefits.


Should you consult a doctor?

If you are undergoing treatment with Hervycta 440 + Injection, it is important to be aware of when to seek medical advice. If you experience symptoms such as breathlessness, cough, shivering, or swelling of legs and arms, it is crucial to inform your doctor promptly. Additionally, any unusual changes in your health, such as persistent nausea, headache, rash, or difficulty sleeping, should be reported to your healthcare provider.


Regular blood tests are necessary to monitor your blood cell levels, heart function, liver health, and blood uric acid levels. If you notice symptoms of anemia, chills, persistent cough, fatigue, fever, or infections, seeking medical attention is advised. It is vital to keep your doctor informed about all medications you are taking, as interactions can occur.


Furthermore, if you are pregnant, breastfeeding, or planning a pregnancy, it is essential to discuss this with your doctor before starting treatment. Using effective contraception during treatment is crucial to prevent pregnancy. Remember, most side effects may subside as your body adjusts, but if they persist or cause concern, consult your healthcare provider.


Side effects of Hervycta 440 + Injection

When using Hervycta 440 + Injection, you may experience various side effects as your body gets used to the medication. These side effects are usually mild and tend to go away on their own without medical intervention. However, if any side effects persist or cause concern, it is advisable to consult your doctor promptly. Some common side effects of Hervycta 440 + Injection include anemia, chills, common cold symptoms, coughing, decreased blood cell counts (affecting red cells, white cells, and platelets), diarrhea, fatigue, fever, headache, heart failure, infections, insomnia (difficulty sleeping), mucosal inflammation, nausea, skin rash, stomatitis (inflammation of the mouth), altered taste perception, upper respiratory tract infections, and weight loss. Be mindful of these potential side effects while using Hervycta 440 + Injection and seek medical advice if needed.


Safety advice

scroll

liver

Caution should be exercised when using Hervycta 440 + Injection in individuals with liver disease. It is advisable to consult with your doctor before starting treatment to ensure safety and efficacy. Limited data is available regarding the use of this injection in patients with liver issues, therefore medical guidance is crucial to minimize any potential risks or adverse effects. Please consult your healthcare provider for personalized advice tailored to your specific liver condition.

scroll

kidney

Hervycta 440 + Injection is considered safe for individuals with kidney disease. Current data indicates that adjusting the dosage for kidney patients may not be required. Consult your doctor for personalized advice.

scroll

alcohol

When using Hervycta 440 + Injection, be cautious as it can lead to increased drowsiness when consumed with alcohol. This combination may intensify the drowsiness effect.

scroll

driving

When using Hervycta 440 + Injection, it is uncertain if it affects driving. Do not drive if you have symptoms impacting concentration or reaction time.

scroll

pregnancy

Hervycta 440 + Injection is considered unsafe during pregnancy due to the risk it poses to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if the benefits outweigh the risks. Consult your doctor before use.

scroll

breastfeeding

Caution for Breastfeeding Hervycta 440 + Injection is considered unsafe during breastfeeding, as there is limited evidence indicating potential harm to the baby through the passage of the drug into breastmilk.


Consumption warning before consuming Hervycta 440 + Injection

Before taking Hervycta 440 + Injection for breast or stomach cancer, it is essential to understand important warnings. This medication works by stopping the growth of cancer cells linked to HER2 protein. Only a qualified medical professional should administer the injection, determining the correct dose based on your condition. Adhering strictly to your doctor's instructions is crucial to avoid severe side effects. Common side effects may include nausea, headache, rash, insomnia, and increased infection risk due to lowered blood cell counts. Regular blood tests are necessary to monitor your blood levels. Inform your doctor immediately if you experience breathlessness, cough, shivering, or swelling. It is vital to disclose all medications to your healthcare team, as interactions can occur. Avoid using this drug during pregnancy or breastfeeding, and practice effective contraception during treatment to prevent pregnancy.


What if you forgot to take Hervycta 440 + Injection?

If you forget to take a dose of Hervycta 440 + Injection, it’s important to speak with your doctor for guidance. In cases of a missed dose, consulting your doctor is crucial to ensure you receive proper instructions on the next steps. It is advisable not to try to compensate for the missed dose by taking extra medication. Your doctor will provide personalized advice on how to proceed to maintain the effectiveness of your treatment. Missing a dose can affect the overall outcome of your therapy, so it is recommended to seek medical advice promptly to address any concerns.


Related lab tests

For patients receiving Hervycta 440 + Injection for the treatment of Breast Cancer, certain related lab tests may be necessary to monitor their condition. These lab tests are critical for assessing the effectiveness of the treatment and determining the progression of the cancer. Specifically, the CA 15.3 test is commonly used to monitor breast cancer patients as it measures the levels of a tumor marker associated with breast cancer. Additionally, testing for hormone receptors ER (estrogen receptor) and PR (progesterone receptor) is important to understand the hormonal status of the cancer. These tests help oncologists make informed decisions about treatment strategies and assess the patient's response to therapy. Monitoring these lab tests regularly can provide valuable insights into the patient's overall health and the effectiveness of the Hervycta 440 + Injection in treating Breast Cancer.


Additional Information

Habit FormingNo
Chemical ClassMonoclonal Antibody
Therapeutic Class-
Action ClassHER2/neu (ErbB2) Inhibitor- Monoclonal antibody

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

61270

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 01-Oct-2024